Log in to save to my catalogue

Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Ge...

Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Ge...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e606fbc718b4edeba30ebaeb46d90db

Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy

About this item

Full title

Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy

Publisher

New York: Springer US

Journal title

Nanoscale research letters, 2020-03, Vol.15 (1), p.57-57, Article 57

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Gene therapy is emerging as a valid method for the treatment of ovarian cancer, including small interfering RNA (siRNA). Although it is so powerful, few targeting efficient gene delivery systems seriously hindered the development of gene therapy. In this study, we synthesized a novel gene vector PEG-GO-PEI-FA by functionalized graphene oxide (GO),...

Alternative Titles

Full title

Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1e606fbc718b4edeba30ebaeb46d90db

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e606fbc718b4edeba30ebaeb46d90db

Other Identifiers

ISSN

1556-276X,1931-7573

E-ISSN

1556-276X

DOI

10.1186/s11671-020-3281-7

How to access this item